Table of contents

Extended reports

• Patient preferences for treatment of rheumatoid arthritis (5 March, 2004)

  L Fraenkel, S T Bogardus, J Concato, D T Felson, D R Wittink
• Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumour necrosis factor α (12 October, 2004)

  S-M Dai, K Nishioka, K Yudoh
• A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells (12 October, 2004)

  N Olsen, T Sokka, C L Seehorn, B Kraft, K Maas, J Moore, T M Aune
• Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis (12 October, 2004)

  T Rooney, E Murphy, M Benito, P Roux-Lombard, O FitzGerald, J-M Dayer, B Bresnihan
• Long term high intensity exercise and damage of small joints in rheumatoid arthritis (12 October, 2004)

  Z de Jong, M Munneke, A H Zwinderman, H M Kroon, K H Ronday, W F Lems, B A C Dijkmans, F C Breedveld, T P M Vliet Vlieland, J M W Hazes, T W J Huizinga
• HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis (12 October, 2004)

  S Laivoranta-Nyman, T Möttönen, R Hermann, J Tuokko, R Luukkainen, M Hakala, P Hannonen, M Korpela, U Yli-Kerttula, A Toivanen, J Ilonen
• Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months’ follow up (22 March, 2004)

  K Bruynesteyn, R Landewé, Sj van der Linden, D van der Heijde
• Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib (27 February, 2004)

  H Tannenbaum, F Berenbaum, J-Y Reginster, J Zacher, J Robinson, G Poor, H Bliddal, D Uebelhart, S Adami, F Navarro, A Lee, A Moore, A Gimona
• Validity and reliability of three definitions of hip osteoarthritis: cross sectional and longitudinal approach (12 October, 2004)

  M Reijman, J M W Hazes, H A P Pols, R M D Bernsen, B W Koes, S M A Bierma-Zeinstra
• Weight changes and the risk of knee osteoarthritis requiring arthroplasty (12 October, 2004)

  P Manninen, H Riihimaki, M Heliövaara, O Suomalainen
• Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis (25 March, 2004)

  J Brandt, J Listing, J Sieper, M Rudwaleit, D van der Heijde, J Braun
• Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease (12 October, 2004)

  M Leiba, U Seligsohn, Y Sidi, D Harats, B A Sela, J H Griffin, A Livneh, N Rosenberg, I Gelernter, H Gur, M Ehrenfeld
• The pustular skin lesions in Behçet’s syndrome are not sterile (12 October, 2004)

  G Hatemi, H Bahar, S Uysal, C Mat, F Gogus, S Masatlioglu, K Altas, H Yazici
• Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts (12 October, 2004)

  J Westra, P C Limburg, P de Boer, M H van Rijswijk
• Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial (12 October, 2004)

  R Buchbinder, J L Hoving, S Green, S Hall, A Forbes, P Nash
• Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation (12 October, 2004)

  K Nissler, D Pohlers, M Hückel, J Simon, R Bräuer, R W Kinne
• High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome (12 October, 2004)

  S Čučnik, T Kveder, I Križaj, B Rozman, B Božič
• Inequalities in access to knee joint replacements for people in need (12 October, 2004)

  P F K Yong, P C Milner, J N Payne, P A Lewis, C Jennison
• Correlation and sex differences between ankle and knee cartilage morphology determined by quantitative magnetic resonance imaging (12 October, 2004)

  F Eckstein, V Siedek, C Glaser, D Al-Ali, K-H Englmeier, M Reiser, H Graichen